The whole healthcare industry has changed drastically over the past few years, probably more so than any other sector, driven by changes in consumer/patient demands, digital disruption, and skyrocketing production costs.

The changes in the healthcare landscape has challenged hospitals, pharmaceutical operations, and other healthcare businesses to think and act strategically about how they shape their processes to meet patient demands while maintaining a healthy business as the environment around them transforms. However, we all know with challenge comes an opportunity to innovate and grow.

 

Some businesses have a distinct advantage…

 

They have a leadership team that have uncovered a new approach to how they innovate within their business – through software innovation, with a streamlined approach to collecting ideas from employees, customers and other stakeholders, with input from a team of technologists.

As a software solution provider, we work with businesses such as ILS Group and FPES amongst others. Innovent understands the innovation needs of people within the industry. Working with our customers, helping to implement ideas that drive down costs, improve patient care, and streamline processes through managed software delivery teams.

 

DRIVING FORCES BEHIND HEALTHCARE TRANSFORMATION

Healthcare is undergoing major changes from within and also has to accommodate governmental changes to data and security and it’s affecting everyone in the industry — from hospitals to insurance to pharmaceuticals to Aged Care. Businesses are starting to rethink and retool their operations to meet the needs and expectations of patients and customers.

 

But what exactly is causing these major changes?

 

And what are healthcare and pharmaceutical businesses doing to evolve along with it?

 

The future of healthcare and pharmaceuticals

There is something exciting bubbling away, which is taking hold and exploding at an exponential rate – an interconnected and convergent trend towards ‘innovative health accelerating technologies’.

New technologies and applications around blockchain and AI, alongside our understanding of disease and the human genome, are re-creating the healthcare landscape. Technologies and frameworks are getting smarter, smaller, faster and, importantly, cheaper. The combination of exponential growth and convergence is enticing as ground-breaking technology and new frameworks gain critical mass, becoming more accessible, leading to mass take-up, rapid growth even to the point of offering free services.

If that is not enough, technological and new developments in genomics, proteomics, imaging and computational bioinformatics mean that we have learnt more about diseases and treatments in the past couple of years than in the whole of history; and our learning is growing exponentially, too.